Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY 4.0BMC Pediatrics

Probable primary bloodstream infection caused by multidrug-resistant Achromobacter piechaudii in an apparently immunocompetent child: a case report

  1. 1Department of Pediatric Critical Care, Chongqing University Three Gorges Hospital, Wanzhou, Chongqing, China

Abstract

Background: Achromobacter piechaudii is an extremely rare opportunistic pathogen in humans. Previous reports of clinical infection have mostly involved adults with underlying conditions such as malignancies or immunocompromised states.This report describes the probable first case of primary, multidrug-resistant Achromobacter piechaudii bloodstream infection in an apparently immunocompetent child.

Case presentation: A previously healthy 10-year-10-month-old boy with no known immunodeficiency or chronic disease was admitted with intermittent headache and fever for 4 days, accompanied by chills, vomiting, and lethargy.He had no recent travel, sick contacts, or known exposure to contaminated water. Complete blood count showed elevated white blood cell count and neutrophil percentage. C-reactive protein and procalcitonin were markedly elevated. Empirical treatment with ceftriaxone was started on admission. On day 2 of hospitalization, blood culture indicated growth of Gram-negative bacilli. On day 3, the isolate was identified as Achromobacter piechaudii by MALDI-TOF MS (score > 2.3). Cerebrospinal fluid examination was normal, confirming primary bloodstream infection. Antimicrobial susceptibility testing showed a multidrug-resistant phenotype. The antibiotic regimen was switched to piperacillin-tazobactam after resistance to ceftriaxone was confirmed.The patient’s fever resolved, clinical symptoms disappeared, and the outcome was favorable.

Conclusion: To our knowledge, this is the probable first case report of primary multidrug-resistant Achromobacter piechaudii bloodstream infection in an apparently immunocompetent child.This case suggests that clinicians should consider rare Achromobacter species when managing pediatric bloodstream infection without obvious immunodeficiency. The multidrug-resistant phenotype highlights the need for accurate species identification and susceptibility-guided therapy.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07498-8.

Related

  1. Anterior Chest Wall Tuberculosis Masquerading as a Chronic Parasternal Sinus in an Apparently Immunocompetent Adult: A Diagnostic Challenge in a Resource-Limited Setting.
    Sharmarke Hassan Ali, Mohamed Mukhtar Mohamed, Mustafe Bile Ismail +1
    International medical case reports journalPeer-reviewedCC BY-NCFull textInfectious diseaseEurope PMCPMC
  2. Prolonged Primary Cytomegalovirus Infection in an Immunocompetent Adult Successfully Treated With Valganciclovir
    Sara K Iguchi, Shogo Shirota, Tomoki Kobayashi +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Pulmonary infection caused by Nocardia cyriacigeorgica and influenza A virus coinfection in an immunocompetent patient : A case report
    Zhengfan Yu, Yanmei Zhang, Lijie Qiu +1
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Risk Factors and Outcomes of Vancomycin-Resistant Enterococcus faecium Bloodstream Infection in Hematologic Malignancies and Stem Cell Transplant Recipients: A Case-Control Study
    Open forum infectious diseasesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Associated factors and a prognostic model for 28-day mortality in Staphylococcus aureus bloodstream infection : A retrospective cohort study
    Zhanpeng Yu, Zeyun Lin, Xiaoyan Tian +6
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
BibTeX
@article{xiang2026probable,
  title = {{Probable primary bloodstream infection caused by multidrug-resistant Achromobacter piechaudii in an apparently immunocompetent child: a case report}},
  author = {Yunfeng Xiang and Ling Duan and Daoxue Xiong and Xiangjun Liu},
  journal = {BMC Pediatrics},
  year = {2026},
  month = aug,
  doi = {10.1186/s12887-026-07498-8},
  url = {https://doi.org/10.1186/s12887-026-07498-8},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Probable primary bloodstream infection caused by multidrug-resistant Achromobacter piechaudii in an apparently immunocompetent child: a case report
AU  - Yunfeng Xiang
AU  - Ling Duan
AU  - Daoxue Xiong
AU  - Xiangjun Liu
PY  - 2026
DA  - 2026/08/10
JO  - BMC Pediatrics
DO  - 10.1186/s12887-026-07498-8
UR  - https://doi.org/10.1186/s12887-026-07498-8
AB  - Background: Achromobacter piechaudii is an extremely rare opportunistic pathogen in humans. Previous reports of clinical infection have mostly involved adults with underlying conditions such as malignancies or immunocompromised states.This report describes the probable first case of primary, multidrug-resistant Achromobacter piechaudii bloodstream infection in an apparently immunocompetent child.  Case presentation: A previously healthy 10-year-10-month-old boy with no known immunodeficiency or chronic disease was admitted with intermittent headache and fever for 4 days, accompanied by chills, vomiting, and lethargy.He had no recent travel, sick contacts, or known exposure to contaminated water. Complete blood count showed elevated white blood cell count and neutrophil percentage. C-reactive protein and procalcitonin were markedly elevated. Empirical treatment with ceftriaxone was started on admission. On day 2 of hospitalization, blood culture indicated growth of Gram-negative bacilli. On day 3, the isolate was identified as Achromobacter piechaudii by MALDI-TOF MS (score > 2.3). Cerebrospinal fluid examination was normal, confirming primary bloodstream infection. Antimicrobial susceptibility testing showed a multidrug-resistant phenotype. The antibiotic regimen was switched to piperacillin-tazobactam after resistance to ceftriaxone was confirmed.The patient’s fever resolved, clinical symptoms disappeared, and the outcome was favorable.  Conclusion: To our knowledge, this is the probable first case report of primary multidrug-resistant Achromobacter piechaudii bloodstream infection in an apparently immunocompetent child.This case suggests that clinicians should consider rare Achromobacter species when managing pediatric bloodstream infection without obvious immunodeficiency. The multidrug-resistant phenotype highlights the need for accurate species identification and susceptibility-guided therapy.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12887-026-07498-8.
SN  - 1471-2431
ER  -